Log in

Relevant bibliographies by topics / KollicoatIR / Journal articles

To see the other types of publications on this topic, follow the link: KollicoatIR.

Journal articles on the topic 'KollicoatIR'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'KollicoatIR.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

SK., Shahanaj* Sasikanth Kothamasu Manohar Babu S. "FORMULATION DEVELOPMENT AND EVALUATION OF FAST RELEASE FILMS OF GALANTAMINE." Indo American Journal of Pharmaceutical Sciences 04, no. 07 (2017): 2164–69. https://doi.org/10.5281/zenodo.837294.

Full text

Abstract:

In the present work efforts have been made to prepare the fast dissolving films of Galantamine using water soluble semi synthetic polymers such as HPMC 3cps, Na CMC and KollicoatIR using plasticizer by means of sodium starch glycolate, super-disintegrants by using the solvent casting method. By comparing with the marketed tablet, the FDFs formulated by means of using superdisintegrant showed fast release for quicker onset of action within minutes. The prepared films were evaluated for physico-chemical properties and invitro release kinetics. The selected formulations produced clear, uniform, f

APA, Harvard, Vancouver, ISO, and other styles

2

V., Madhu Sudarsan* S.T.V. Raghavamma N. Rama Rao. "FORMULATION AND EVALUATION OF METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS COMPRISING COATED PELLETS." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES o6, no. 08 (2019): 14659–74. https://doi.org/10.5281/zenodo.3368085.

Full text

Abstract:

<em>The objective of the present study was for improving bioavailability and reducing the dosage frequency of Metoprolol succinate in the form of extended release pellets by pan coating technology.</em><em> Preliminary studies with different polymers such as Surelase, Ethyl cellulose N50, Kollicoat SR 30D were performed. The results of in-vitro release data showed that Kollicoat SR 30D can Extend the drug release up to 24hr. Metoprolol succinate extended release tablets were prepared by MUPS Technique. The hardness of these extended release tablets was within the limit. The drug content was wi

APA, Harvard, Vancouver, ISO, and other styles

3

Komanduri, Neeraja, Mashan Almutairi, Rasha M. Elkanayati, et al. "Kollicoat® Smartseal 100P for Developing Theophylline Pellets: Exploring Taste-Masking Potential for Pediatric Applications." Pharmaceutics 17, no. 4 (2025): 413. https://doi.org/10.3390/pharmaceutics17040413.

Full text

Abstract:

Background/Objectives: This study aimed to develop and evaluate taste-masked theophylline pellets using hot-melt extrusion (HME) technology. Additionally, the study evaluates the efficacy of various taste-masking polymers by comparing three pH-dependent polymers, Kollicoat® Smartseal 100P, Eudragit® EPO, and Kollicoat® MAE 100-55, in masking taste and optimizing drug release. Methods: Formulations were designed with varying drug loads (10%, 20%, and 30%) and plasticizer concentrations (20% and 30% PEG 1500). Lead formulations were characterized using differential scanning calorimetry (DSC), Fo

APA, Harvard, Vancouver, ISO, and other styles

4

Fouad, Ehab A., Mahmoud El-Badry, Steven H. Neau, Fars K. Alanazi, and Ibrahim A. Alsarra. "Technology evaluation: Kollicoat IR." Expert Opinion on Drug Delivery 8, no. 5 (2011): 693–703. http://dx.doi.org/10.1517/17425247.2011.566266.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Luke, Stefani, Martha Ervina, and Lannie Hadisoewignyo. "Optimization of Coating Formula of White Pomegranate Peel Extract (Punica granatum L.) Film Coated Tablet Using Kollicoat Protect." Indonesian Journal of Pharmaceutical Research 1, no. 1 (2021): 19–27. http://dx.doi.org/10.31869/ijpr.v1i1.1993.

Full text

Abstract:

White pomegranate peel has many kinds uses, one of them as antimalaria. The unpleasant appearance and bitter taste of white pomegranate peel tablet can be covered by film coated using Kollicoat Protect. This research aimed to determine the effect of concentration and type of solvent used as a coating on the physical properties of the coated tablets and determine the optimum formula. Tablets were made using direct compression method and then coated using Kollicoat Protect. The optimization of coating formula was performed using a factorial design with design expert software ver 10.0. Responses

APA, Harvard, Vancouver, ISO, and other styles

6

Rahman, Tanvir, Md Abdurrahim, Koma Afrin Rintu, et al. "Improvement of in vitro dissolution profile of poorly aqueous soluble anti-parasitic agent ivermectin using novel hydrophilic polymeric carriers." Bangladesh Journal of Scientific and Industrial Research 58, no. 4 (2023): 209–20. http://dx.doi.org/10.3329/bjsir.v58i4.69047.

Full text

Abstract:

Ivermectin (IVM), a BCS Class II drug with weak water solubility, has minimal oral absorption and dissolution. This study aims to enhance the dissolution profile of IVM by performing solid dispersion methods using four hydrophilic polymers: Kollicoat IR, Kollidon 90F, poloxamer 407, and hydroxypropyl methylcellulose (HPMC). The solid dispersion formulations (SDF) were made through physical mixing, solvent evaporation, and melt solvent/fusion. Using three ratios of IVM and hydrophilic carriers (1:1, 1:2, and 1:3), the cumulative release rate of IVM from formulations formed by physical mixing, s

APA, Harvard, Vancouver, ISO, and other styles

7

Xi, Ziyue, Wei Zhang, Yali Fei, et al. "Evaluation of the Solid Dispersion System Engineered from Mesoporous Silica and Polymers for the Poorly Water Soluble Drug Indomethacin: In Vitro and In Vivo." Pharmaceutics 12, no. 2 (2020): 144. http://dx.doi.org/10.3390/pharmaceutics12020144.

Full text

Abstract:

This work explored absorption efficacy via an in vivo imaging system and parallel artificial membrane penetration in indomethacin (IMC) solid dispersion (SD) systems. Two different polymer excipients—hydroxypropyl methylcellulose (HPMC) and Kollicoat IR as precipitation inhibitors (PIs)—combined with mesoporous silica nanoparticles (MSNs) as carriers were investigated. The IMC–SDs were prepared using the solvent evaporation method and characterized by solubility analysis, infrared (IR) spectroscopy, powder X-ray diffraction (PXRD), field emission scanning electron microscopy (FESEM), and diffe

APA, Harvard, Vancouver, ISO, and other styles

8

P.Eswaramma*, M.Vijaya kumari G.Sruthi V.Yamini Saraswathi A. Naveen Kumar G. Rajasekhar M. Raja Rathnam. "FORMULATION AND EVALUATION OF EXTENDED RELEASE PELLETS OF METOPROLOL SUCCINATE." Indo American Journal of Pharmaceutical Sciences 04, no. 08 (2017): 2308–20. https://doi.org/10.5281/zenodo.843647.

Full text

Abstract:

The objective of the present study was to formulate and develop extended release drug delivery system of antihypertensive drug Metoprolol succinate . The major indications of Metoprolol succinate is treatment and management of hypertension, angina, acute myocardial infarction, supraventricular tachycardia, congestive heart faiure, and migrane. Hypertension (HTN)is a chronic medical condition in which the blood pressure in the arteries is elevated. High blood pressure is said to be present if it is persistently at or above 140/90 mmHg pressure . The dosage for adults is 2-3 times a day, to redu

APA, Harvard, Vancouver, ISO, and other styles

9

Fahier, Julie, Branko Vukosavljevic, Laure De Kinder, et al. "Towards a Better Understanding of Verapamil Release from Kollicoat SR:IR Coated Pellets Using Non-Invasive Analytical Tools." Pharmaceutics 13, no. 10 (2021): 1723. http://dx.doi.org/10.3390/pharmaceutics13101723.

Full text

Abstract:

The aim of this study was to gain deeper insight into the mass transport mechanisms controlling drug release from polymer-coated pellets using non-invasive analytical tools. Pellet starter cores loaded with verapamil HCl (10% loading, 45% lactose, 45% microcrystalline cellulose) were prepared by extrusion/spheronization and coated with 5% Kollicoat SR:IR 95:5 or 10% Kollicoat SR:IR 90:10. Drug release was measured from ensembles of pellets as well as from single pellets upon exposure to acetate buffer pH = 3.5 and phosphate buffer pH = 7.4. The swelling of single pellets was observed by optica

APA, Harvard, Vancouver, ISO, and other styles

10

Maraie, Nidhal K., Zeina D. Salman, and Nora Zawar Yousif. "DESIGN AND CHARACTERIZATION OF OROSLIPPERY BUOYANT TABLETS FOR RANITIDINE HYDROCHLORIDE." Asian Journal of Pharmaceutical and Clinical Research 11, no. 1 (2018): 143. http://dx.doi.org/10.22159/ajpcr.2017.v11i1.21982.

Full text

Abstract:

Objective: The goal behind of performing this study was to come out with an oroslippery buoyant ranitidine hydrochloride tablet to ease the swallowing process. Hence, the drug is released controllably in the stomach regardless of the effect on gastric emptying time.Materials and Methods: The core of the buoyant containing 150 mg of the drug was compressed directly, and sodium bicarbonate was employed as an effervescent agent, besides, hydroxyl propyl methyl cellulose (HPMC) polymer was utilized in different grades in the formulation process. The prepared core was immersed in the coating disper

APA, Harvard, Vancouver, ISO, and other styles

11

Maraie, Nidhal K., Zeina D. Salman, and Nora Zawar Yousif. "DESIGN AND CHARACTERIZATION OF OROSLIPPERY BUOYANT TABLETS FOR RANITIDINE HYDROCHLORIDE." Asian Journal of Pharmaceutical and Clinical Research 11, no. 1 (2018): 143. http://dx.doi.org/10.22159/ajpcr.2018.v11i1.21982.

Full text

Abstract:

Objective: The goal behind of performing this study was to come out with an oroslippery buoyant ranitidine hydrochloride tablet to ease the swallowing process. Hence, the drug is released controllably in the stomach regardless of the effect on gastric emptying time.Materials and Methods: The core of the buoyant containing 150 mg of the drug was compressed directly, and sodium bicarbonate was employed as an effervescent agent, besides, hydroxyl propyl methyl cellulose (HPMC) polymer was utilized in different grades in the formulation process. The prepared core was immersed in the coating disper

APA, Harvard, Vancouver, ISO, and other styles

12

Serrano-Castañeda, Pablo, Miguel Alejandro Ochoa Loyo, Cristian Ezequiel Tinoco Hernández, et al. "Ceftriaxone-Loaded Polymeric Microneedles, Dressings, and Microfibers for Wound Treatment." Polymers 15, no. 12 (2023): 2610. http://dx.doi.org/10.3390/polym15122610.

Full text

Abstract:

The objective of this study was to create polymeric dressings, microfibers, and microneedles (MN) loaded with ceftriaxone, using PMVA (Poly (Methyl vinyl ether-alt-maleic acid), Kollicoat® 100P, and Kollicoat® Protect as polymers to treat diabetic wounds and accelerate their recovery. These formulations were optimized through a series of experiments and were subsequently subjected to physicochemical tests. The results of the characterization of the dressings, microfibers, and microneedles (PMVA and 100P) were, respectively, a bioadhesion of 281.34, 720, 720, 2487, and 510.5 gf; a post-humectat

APA, Harvard, Vancouver, ISO, and other styles

13

Helmis, Mario, and Mont Kumpugdee-Vollrath. "Polymer Mixtures as Colon Targeted Drug Delivery Systems." Advanced Materials Research 690-693 (May 2013): 2131–36. http://dx.doi.org/10.4028/www.scientific.net/amr.690-693.2131.

Full text

Abstract:

For the development of colon delivery systems (CDS) formulations have to be gastric resistant. The advantage of the CDS is the ability for a local treatment for colon diseases but also its systemic action. CDS can also increase the bioavailability of poorly water soluble drugs e.g. resveratrol, which can be degraded in the upper gastrointestinal tract or by the First-Pass-Effect. In this project the coating technique with different polymer mixtures containing Kollicoat MAE-30DP, Eudragit-NM, Eudragit-L, and Eudragit-NE was investigated. Resveratrol was used as a model drug and all formulations

APA, Harvard, Vancouver, ISO, and other styles

14

Cuppok, Y., S. Muschert, M. Marucci, et al. "Drug release mechanisms from Kollicoat SR:Eudragit NE coated pellets." International Journal of Pharmaceutics 409, no. 1-2 (2011): 30–37. http://dx.doi.org/10.1016/j.ijpharm.2011.02.026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Khobragade, Deepak S., K. Vighneshwar, and Mrunali S. Potbhare. "Development and Evaluation of Novel Multi-unit Pellet System Formulation of Metoprolol Succinate for Extended Release." INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY 12, no. 03 (2022): 1219–27. http://dx.doi.org/10.25258/ijddt.12.3.49.

Full text

Abstract:

Metaprolol succinate is a highly water-soluble drug with extensive first-pass metabolism. It needs to be administered about 3-4 times a day for optimum therapeutic effect. Conventional extended-release formulations are available but have their own disadvantages. The study was to designed formulate and evaluate the prolonged-release compressed multiple-unit pellet system of Metoprolol succinate. MUPS are novel formulations with benefits of both single and multi unit dosage forms and can provide extended drug delivery release profile and increase the efficiency profile of the drug. Metaprolol su

APA, Harvard, Vancouver, ISO, and other styles

16

Sharma, Manisha, Amit Mishra, Vinod Kumar, and Soumen Basu. "Green Synthesis of Silver Nanoparticles with Exceptional Colloidal Stability and its Catalytic Activity Toward Nitrophenol Reduction." Nano 11, no. 04 (2016): 1650046. http://dx.doi.org/10.1142/s1793292016500466.

Full text

Abstract:

Silver nanoparticles (Ag NPs) were synthesized by one-step process in the presence of kollicoat as capping, reducing and stabilizing mediator. The synthesized NPs were characterized by using FTIR, TEM, DLS, XRD, EDS and UV-Vis spectroscopy. The resulting Ag NPs had an incomparable colloidal stability against the salt addition and change of pH. The effect of different synthesis parameters and the catalytic property of the NPs were examined.

APA, Harvard, Vancouver, ISO, and other styles

17

Li, Yingjian, and Dale Eric Wurster. "A study of Kollicoat® MAE100P film’s structure and properties." International Journal of Pharmaceutics 606 (September 2021): 120622. http://dx.doi.org/10.1016/j.ijpharm.2021.120622.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Dangel, C., G. Schepky, H. B. Reich, and K. Kolter. "Comparative Studies with Kollicoat MAE 30 D and Kollicoat MAE 30 DP in Aqueous Spray Dispersions and Enteric Coatings on Highly Swellable Caffeine Cores." Drug Development and Industrial Pharmacy 26, no. 4 (2000): 415–21. http://dx.doi.org/10.1081/ddc-100101248.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Abdelhakim, Hend E., Alastair Coupe, Catherine Tuleu, Mohan Edirisinghe, and Duncan Q. M. Craig. "Utilising Co-Axial Electrospinning as a Taste-Masking Technology for Paediatric Drug Delivery." Pharmaceutics 13, no. 10 (2021): 1665. http://dx.doi.org/10.3390/pharmaceutics13101665.

Full text

Abstract:

The present study describes the use of two taste-masking polymers to fabricate a formulation of chlorpheniramine maleate for paediatric administration. Co-axial electrospinning was utilized to create layered nanofibres; the two polymers, Eudragit® E PO and Kollicoat® Smartseal, were alternated between the core and the shell of the system in order to identify the optimum taste-masked formulation. The drug was loaded in the core on all occasions. It was found that the formulation with Kollicoat® Smartseal in the core with the drug, and Eudragit® E PO in the shell showed the most effective taste-

APA, Harvard, Vancouver, ISO, and other styles

20

Kovalenko, Lakija, Kirils Kukuls, Marta Berga, and Valentyn Mohylyuk. "Taste-Masked Pellets of Warfarin Sodium: Formulation towards the Dose Personalisation." Pharmaceutics 16, no. 5 (2024): 586. http://dx.doi.org/10.3390/pharmaceutics16050586.

Full text

Abstract:

The bitter drug, warfarin, has a narrow therapeutic index (NTI) and is used in paediatrics and geriatrics. The aim of this feasibility study was to formulate the taste-masked warfarin-containing pellets to be applicable for dose personalisation and to improve patient compliance, as well as to investigate the effect of the core type (PharSQ® Spheres M, CELPHERE™ CP-507, and NaCl) on the warfarin release from the Kollicoat® Smartseal taste-masking-coated pellets. The cores were successfully drug-loaded and coated in a fluid-bed coater with a Wurster insert. An increase in particle size and parti

APA, Harvard, Vancouver, ISO, and other styles

21

Godge, GR, and SN Hiremath. "Development and evaluation of colon targeted drug delivery system by using natural Polysaccharides/Polymers." Dhaka University Journal of Pharmaceutical Sciences 13, no. 1 (2015): 105–13. http://dx.doi.org/10.3329/dujps.v13i1.21874.

Full text

Abstract:

Colon is being extensively investigated as a drug delivery site. This study contains comparison of the usual enteric coating polymers viz. xanthan gum, guar gum, chitosan and ethyl cellulose, as carriers for colon specific drug delivery. Lactose based metoprolol succinate tablets were prepared. These were coated with one of the coating polymers to a varying coat thickness. Tablets were prepared using polysaccharides or synthetic polymer as binders. These included xanthan gum, guar gum, chitosan and ethyl cellulose. Metoprolol Succinate was used as a model drug. The prepared tablets were enteri

APA, Harvard, Vancouver, ISO, and other styles

22

Yamamoto, S., Y. Kaneo, T. Ishizu, Y. Yamaguchi, and H. Haraguchi. "Incorporation of Amphotericin B Into Self-Assembled Hydrophobized Kollicoat IR Nanoparticles." Journal of Drug Delivery Science and Technology 23, no. 6 (2013): 591–96. http://dx.doi.org/10.1016/s1773-2247(13)50090-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Li-Fang, Fan, He Wei, Chang Yong-Zhen, et al. "Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery." International Journal of Pharmaceutics 375, no. 1-2 (2009): 8–15. http://dx.doi.org/10.1016/j.ijpharm.2009.03.023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Flößer, A., K. Kolter, H. B. Reich, and G. Schepky. "Variation of Composition of an Enteric Formulation Based on Kollicoat MAE 30 D." Drug Development and Industrial Pharmacy 26, no. 2 (2000): 177–87. http://dx.doi.org/10.1081/ddc-100100342.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Ruiz, M. A., V. Gallardo, N. Ouazzani, J. López-Viota, and J. D. G. López-Durán. "Electrophoretic properties of acrylic latex suspensions (Kollicoat®MAE 30 D) and ibuprofen." Il Farmaco 59, no. 8 (2004): 657–62. http://dx.doi.org/10.1016/j.farmac.2004.03.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Wei, He, Fan Li-Fang, Bai Min, et al. "Chitosan/Kollicoat SR 30D film-coated pellets of aminosalicylates for colonic drug delivery." Journal of Pharmaceutical Sciences 99, no. 1 (2010): 186–95. http://dx.doi.org/10.1002/jps.21810.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kazmi, Imran, Fahad A. Al-Abbasi, Muhammad Afzal, Hisham N. Altayb, Muhammad Shahid Nadeem, and Gaurav Gupta. "Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies." Pharmaceutics 13, no. 12 (2021): 2086. http://dx.doi.org/10.3390/pharmaceutics13122086.

Full text

Abstract:

The present study was designed to prepare Kaempferol loaded nanoparticles (KFP-Np) and evaluate hepatoprotective and antioxidant effects in hepatocellular carcinoma models. KFP was encapsulated with hydroxypropyl methylcellulose acetate succinate (HPMC-AS) and Kollicoat MAE 30 DP polymers to prepare nanoparticles (Nps) by quasi-emulsion solvent diffusion technique (QESD). The prepared Nps were evaluated for different pharmaceutical characterization to select the optimum composition for the in vivo assessment. An animal model of cadmium chloride (CdCl2)-induced hepatocellular carcinoma in Male

APA, Harvard, Vancouver, ISO, and other styles

28

Partheniadis, Ioannis, Miltiadis Toskas, Filippos-Michail Stavras, Georgios Menexes, and Ioannis Nikolakakis. "Impact of Hot-Melt-Extrusion on Solid-State Properties of Pharmaceutical Polymers and Classification Using Hierarchical Cluster Analysis." Processes 8, no. 10 (2020): 1208. http://dx.doi.org/10.3390/pr8101208.

Full text

Abstract:

The impact of hot-melt extrusion (HME) on the solid-state properties of four methacrylic (Eudragit® L100-55, Eudragit® EPO, Eudragit® RSPO, Eudragit® RLPO) and four polyvinyl (Kollidon® VA64, Kollicoat® IR, Kollidon® SR, and Soluplus®) polymers was studied. Overall, HME decreased Tg but increased electrostatic charge and surface free energy. Packing density decreased with electrostatic charge, whereas Carr’s and Hausner indices showed a peak curve dependency. Overall, HME reduced work of compaction (Wc), deformability (expressed as Heckel PY and Kawakita 1/b model parameters and as slope S′ of

APA, Harvard, Vancouver, ISO, and other styles

29

Sahana, G* Nagaraja T. S. Vitthal k. vijapur Bharathi D. R. "DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF COLON SPECIFIC MICRROSPHERES OF BUDESONIDE." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES o6, no. 06 (2019): 13097–104. https://doi.org/10.5281/zenodo.3257974.

Full text

Abstract:

<em>The objective of the present study was to development, characterization and evaluation of colon specific microspheres of Budesonide. To achieve these objective nine formulations of microspheres were prepared by emulsion solvent evaporation method using Eudragit RS100 and Kollicoat MAE 100 P polymer. Prepared microspheres were evaluated for Particle size analysis, Surface morphology, Differential scanning calorimetric analysis, Fourier transform infrared spectroscopy analysis, X-ray diffraction studies, Drug encapsulation efficiency, In-vitro drug release study and Stability study. The micr

APA, Harvard, Vancouver, ISO, and other styles

30

Dashevsky, A., K. Kolter, and R. Bodmeier. "pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat® SR 30 D and the enteric polymer dispersion Kollicoat® MAE 30 DP." European Journal of Pharmaceutics and Biopharmaceutics 58, no. 1 (2004): 45–49. http://dx.doi.org/10.1016/j.ejpb.2004.03.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

El-Badry, M. "Improvement of the in vitro release of omeprazole from suppository bases using Kollicoat IR." Journal of Drug Delivery Science and Technology 20, no. 5 (2010): 391–96. http://dx.doi.org/10.1016/s1773-2247(10)50064-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Sawicki, Wiesław, and Rafał Łunio. "Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D." European Journal of Pharmaceutics and Biopharmaceutics 60, no. 1 (2005): 153–58. http://dx.doi.org/10.1016/j.ejpb.2004.11.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Lemke, Stefan, and Mont Kumpugdee-Vollrath. "Controlled Release of Tablets Containing Poorly Water Soluble Model Drug Coated with Kollicoat MAE 30DP." Advanced Materials Research 418-420 (December 2011): 2186–89. http://dx.doi.org/10.4028/www.scientific.net/amr.418-420.2186.

Full text

Abstract:

In this project we have prepared the tablets with a coating of pH-sensitive polymer Kollicoat MAE 30DP. For this purpose the core tablets prepared from poorly water soluble model drug and other excipients were coated by a fluidized bed apparatus at the exhaust air temperature of 30°C and spraying rate of 0.55 g/min. The highest coating time was 384 min which leads to the film thickness of 648 µm. The coated tablets were gastric resistant for one hour and resistant against intestinal fluid pH 6.8 up to 70 min. The coating film has a good quality with smoothness and dense packing. However, if th

APA, Harvard, Vancouver, ISO, and other styles

34

Dashevskiy, Andriy, Valentyn Mohylyuk, Abid Riaz Ahmed, Karl Kolter, Felicitas Guth, and Roland Bodmeier. "Micropellets coated with Kollicoat® Smartseal 30D for taste masking in liquid oral dosage forms." Drug Development and Industrial Pharmacy 43, no. 9 (2017): 1548–56. http://dx.doi.org/10.1080/03639045.2017.1323910.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Erdmann, H., S. Gebert, K. Kolter, and G. Schepky. "Studies on Modifying the Tackiness and Drug Release of Kollicoat® EMM 30 D Coatings." Drug Development and Industrial Pharmacy 29, no. 4 (2003): 429–40. http://dx.doi.org/10.1081/ddc-120018378.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Wei, He, Fan Li-Fang, Xiang Bai, et al. "An investigation into the characteristics of chitosan/Kollicoat SR30D free films for colonic drug delivery." European Journal of Pharmaceutics and Biopharmaceutics 72, no. 1 (2009): 266–74. http://dx.doi.org/10.1016/j.ejpb.2008.10.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Paczkowska-Walendowska, Magdalena, Lidia Tajber, Andrzej Miklaszewski, and Judyta Cielecka-Piontek. "Hot Melt Extrusion for Improving the Physicochemical Properties of Polydatin Derived from Polygoni cuspidati Extract; A Solution Recommended for Buccal Applications." Pharmaceuticals 16, no. 9 (2023): 1226. http://dx.doi.org/10.3390/ph16091226.

Full text

Abstract:

Three different types of solid dispersions based on polyvinyl polymers and related copolymers (Kollidon® VA64, Soluplus® and Kollicoat IR®) comprising polydatin-rich Polygoni cuspidati extract were prepared by hot melt extrusion. The systems were characterized using X-ray powder diffraction, infrared spectroscopy as well as by polydatin release and in vitro permeability. Mucoadhesive tablets were prepared from the extrudates based on Kollidon® VA64 and Soluplus® to obtain a suitable pharmaceutical form, where (hydroxypropyl)methyl cellulose was added as a mucoadhesive agent. The tablets were e

APA, Harvard, Vancouver, ISO, and other styles

38

Scheiffele, Silke, Karl Kolter, and Gottfried Schepky. "Studies Comparing Kollicoat MAE 30 D with Commercial Cellulose Derivatives for Enteric Coating on Caffeine Cores." Drug Development and Industrial Pharmacy 24, no. 9 (1998): 807–18. http://dx.doi.org/10.3109/03639049809088525.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Andreazza, Itamar Francisco, and Humberto Gomes Ferraz. "Preparation of pellets containing highly soluble drug by extrusion/spheronisation and coating with Kollicoat® SR 30D." Brazilian Archives of Biology and Technology 54, no. 2 (2011): 315–20. http://dx.doi.org/10.1590/s1516-89132011000200013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Shao, Zezhi J., Luis Morales, Steven Diaz, and Nouman A. Muhammad. "Drug release from kollicoat SR 30D-coated nonpareil beads: Evaluation of coating level, plasticizer type, and curing condition." AAPS PharmSciTech 3, no. 2 (2002): 87–96. http://dx.doi.org/10.1208/pt030215.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Xi, Ziyue, Wei Zhang, Zisen Gao, et al. "Preparation and dissolution characteristic evaluation of carvedilol-Kollicoat IR solid dispersions with HPMC and MC as combined carriers." Powder Technology 360 (January 2020): 1220–26. http://dx.doi.org/10.1016/j.powtec.2019.10.095.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Petry, Ina, Korbinian Löbmann, Holger Grohganz, Thomas Rades, and Claudia S. Leopold. "Solid state properties and drug release behavior of co-amorphous indomethacin-arginine tablets coated with Kollicoat® Protect." European Journal of Pharmaceutics and Biopharmaceutics 119 (October 2017): 150–60. http://dx.doi.org/10.1016/j.ejpb.2017.06.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Janssens, Sandrien, Hector Novoa de Armas, Jean Paul Remon, and Guy Van den Mooter. "The use of a new hydrophilic polymer, Kollicoat IR®, in the formulation of solid dispersions of Itraconazole." European Journal of Pharmaceutical Sciences 30, no. 3-4 (2007): 288–94. http://dx.doi.org/10.1016/j.ejps.2006.11.015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Drechsler, Michael, Grzegorz Garbacz, Ralf Thomann, and Rolf Schubert. "Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting." European Journal of Pharmaceutics and Biopharmaceutics 88, no. 3 (2014): 807–15. http://dx.doi.org/10.1016/j.ejpb.2014.09.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Awad, Atheer, Fabrizio Fina, Sarah Trenfield, et al. "3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology." Pharmaceutics 11, no. 4 (2019): 148. http://dx.doi.org/10.3390/pharmaceutics11040148.

Full text

Abstract:

Selective laser sintering (SLS) is a single-step three-dimensional printing (3DP) process that can be leveraged to engineer a wide array of drug delivery systems. The aim of this work was to utilise SLS 3DP, for the first time, to produce small oral dosage forms with modified release properties. As such, paracetamol-loaded 3D printed multiparticulates, termed miniprintlets, were fabricated in 1 mm and 2 mm diameters. Despite their large surface area compared with a conventional monolithic tablet, the ethyl cellulose-based miniprintlets exhibited prolonged drug release patterns. The possibility

APA, Harvard, Vancouver, ISO, and other styles

46

Chivate, Amit, Vishnu Sargar, Pravin Nalawade, and Vaishali Tawde. "Formulation and development of oral dry suspension using taste masked Ornidazole particles prepared using Kollicoat®Smartseal 30 D." Drug Development and Industrial Pharmacy 39, no. 7 (2012): 1091–97. http://dx.doi.org/10.3109/03639045.2012.709250.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Xu, L., S. M. Li, Y. Wang, M. Wei, H. M. Yao, and H. Sunada. "Improvement of dissolution rate of ibuprofen by solid dispersion systems with Kollicoat IR using a pulse combustion dryer system." Journal of Drug Delivery Science and Technology 19, no. 2 (2009): 113–18. http://dx.doi.org/10.1016/s1773-2247(09)50018-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

., Padmnabh, and DC Bhatt. "Formulation, Optimization, and Evaluation of Gliclazide loaded Nanosuspension for Dissolution Rate Enhancement." INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE 14, no. 04 (2023): 1107–14. http://dx.doi.org/10.25258/ijpqa.14.4.45.

Full text

Abstract:

Diabetes mellitus is a prolonged metabolic condition categorized through elevated blood glucose levels. To treat this condition, oral antihyperglycemic medications like gliclazide, a second-generation sulfonylurea insulin secretagogue, are commonly used. Gliclazide comes into the biopharmaceutical classification system (BCS) class-II types, known for its lower solubility. To enhance its solubility, gliclazide was integrated into nanosuspensions. This study focused on formulating these gliclazide nanosuspensions using Kollicoat IR and Soluplus through the anti-solvent-precipitation method, thro

APA, Harvard, Vancouver, ISO, and other styles

49

Salehi, Sahar, and Soheil Boddohi. "Design and optimization of kollicoat ® IR based mucoadhesive buccal film for co-delivery of rizatriptan benzoate and propranolol hydrochloride." Materials Science and Engineering: C 97 (April 2019): 230–44. http://dx.doi.org/10.1016/j.msec.2018.12.036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Buyukgoz, Guluzar Gorkem, Christopher Gordon Kossor, and Rajesh N. Davé. "Enhanced Supersaturation via Fusion-Assisted Amorphization during FDM 3D Printing of Crystalline Poorly Soluble Drug Loaded Filaments." Pharmaceutics 13, no. 11 (2021): 1857. http://dx.doi.org/10.3390/pharmaceutics13111857.

Full text

Abstract:

Filaments loaded with griseofulvin (GF), a model poorly water-soluble drug, were prepared and used for 3D printing via fused deposition modeling (FDM). GF was selected due to its high melting temperature, enabling lower temperature hot-melt extrusion (HME) keeping GF largely crystalline in the filaments, which could help mitigate the disadvantages of high HME processing temperatures such as filament quality, important for printability and the adverse effects of GF recrystallization on tablet properties. Novel aspects include single-step fusion-assisted ASDs generation during FDM 3D printing an

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!